2010
DOI: 10.1016/j.ecolecon.2010.09.030
|View full text |Cite
|
Sign up to set email alerts
|

The pharmaceutical value of marine biodiversity for anti-cancer drug discovery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
44
0
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 73 publications
(48 citation statements)
references
References 34 publications
0
44
0
1
Order By: Relevance
“…In addition to marine sponges, didemnid ascidians present an interesting environment for the investigation of symbiotic relationships (Adams, 2002;Hirose and Maruyama, 2004) and the discovery of new bioactive compounds (Sings and Rinehart, 1996;Ogi et al, 2009;Erwin et al, 2010). The role and importance of ascidian-associated microbes versus the host as a source of such secondary metabolites remains largely unexplored.…”
Section: Introductionmentioning
confidence: 99%
“…In addition to marine sponges, didemnid ascidians present an interesting environment for the investigation of symbiotic relationships (Adams, 2002;Hirose and Maruyama, 2004) and the discovery of new bioactive compounds (Sings and Rinehart, 1996;Ogi et al, 2009;Erwin et al, 2010). The role and importance of ascidian-associated microbes versus the host as a source of such secondary metabolites remains largely unexplored.…”
Section: Introductionmentioning
confidence: 99%
“…As a basal lineage in the phylum Chordata, ascidians occupy a key stage in deuterostome evolution (Delsuc et al, 2006). Ascidians are also a prolific source of novel marine natural products (Erwin et al, 2010) and the involvement of microbial symbionts in bioactive compound production (Schmidt and Donia, 2010) has prompted recent studies of the ascidian microbiota (Donia et al, 2011;Kwan et al, 2012). Historically, most studies of microbial symbionts in ascidians have focused on cyanobacteria, in particular the genera Prochloron and Synechocystis.…”
Section: Introductionmentioning
confidence: 99%
“…Further, symbiont biosynthesis of secondary metabolites contributes to the chemical defenses of marine invertebrates (Schmidt et al, 2005;Freeman et al, 2012), a key strategy for sessile organisms to deter predation, avoid surface fouling and compete for substrate (Armstrong et al, 2001;Pawlik, 2011). In addition to their roles in host biology and ecology, many of these unique and structurally diverse secondary metabolites have pharmaceutical applications and substantial importance for biotechnology and drug discovery (Paul and Ritson-Williams, 2008;Erwin et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…9,10) In addition, several natural products from marine organisms have been reported to express bioactivity against prevalent diseases such as cancer, diabetes, and obesity. [11][12][13] So far, numerous compounds isolated from natural resources have been reported to exhibit significant anti-HIV activity and inhibit HIV-1 activity in almost every stage of the viral life cycle. 14) Polysaccharides and phlorotannins isolated from the marine algae show distinct inhibitory activity against HIV-1 reproduction as well as viral infection.…”
mentioning
confidence: 99%